Literature DB >> 8148330

Human T lymphotropic virus type 1 uveitis after Graves' disease.

K Yamaguchi1, M Mochizuki, T Watanabe, K Yoshimura, M Shirao, S Araki, N Miyata, S Mori, T Kiyokawa, K Takatsuki.   

Abstract

A distinct clinical entity of uveitis associated with human T lymphotropic virus type 1 (HTLV-I) has been reported previously. During the period between January 1989 and April 1992, 93 patients were observed with HTLV-I uveitis and a significant correlation was found between Graves' disease and HTLV-I uveitis. Sixteen of the 93 patients with HTLV-I uveitis (17.2%) had a previous history of Graves' disease. Fifteen patients were female (15/60, 25.0%) and one was male (1/33, 3.0%). Interestingly, uveitis occurred after the onset of Graves' disease in all cases. On the other hand, none of 222 patients with idiopathic uveitis who were seronegative to HTLV-I had a history of Graves' disease. Although the mechanisms by which HTLV-I causes the correlation between uveitis and Graves' disease are unknown, the present data suggest that immune mediated or autoimmune mechanisms are involved in HTLV-I uveitis.

Entities:  

Mesh:

Year:  1994        PMID: 8148330      PMCID: PMC504729          DOI: 10.1136/bjo.78.3.163

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  17 in total

1.  Sjögren's syndrome-like illness associated with the acquired immunodeficiency syndrome-related complex.

Authors:  R C Ulirsch; E S Jaffe
Journal:  Hum Pathol       Date:  1987-10       Impact factor: 3.466

2.  T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome.

Authors:  J C Vernant; G Buisson; J Magdeleine; J De Thore; A Jouannelle; C Neisson-Vernant; N Monplaisir
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

3.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

4.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

5.  Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I.

Authors:  S Z Salahuddin; P D Markham; S G Lindner; J Gootenberg; M Popovic; H Hemmi; P S Sarin; R C Gallo
Journal:  Science       Date:  1984-02-17       Impact factor: 47.728

6.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

Authors:  M Yoshida; M Seiki; K Yamaguchi; K Takatsuki
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Clinical and immunologic features of human T-cell lymphotropic virus type I uveitis.

Authors:  K Yoshimura; M Mochizuki; S Araki; N Miyata; K Yamaguchi; K Tajima; T Watanabe
Journal:  Am J Ophthalmol       Date:  1993-08-15       Impact factor: 5.258

8.  On the mechanism of thrombocytopenic purpura in sexually active homosexual men.

Authors:  C M Walsh; M A Nardi; S Karpatkin
Journal:  N Engl J Med       Date:  1984-09-06       Impact factor: 91.245

9.  Autoimmune thrombocytopenic purpura in homosexual men.

Authors:  L Morris; A Distenfeld; E Amorosi; S Karpatkin
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

10.  Multiple sclerosis and human T-cell lymphotropic retroviruses.

Authors:  H Koprowski; E C DeFreitas; M E Harper; M Sandberg-Wollheim; W A Sheremata; M Robert-Guroff; C W Saxinger; M B Feinberg; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

View more
  9 in total

1.  Association Between Thyroid Disease and Uveitis: Results From the Pacific Ocular Inflammation Study.

Authors:  Durga S Borkar; Gelareh Homayounfar; Vivien M Tham; Kathryn J Ray; Aleli C Vinoya; Aileen Uchida; Nisha R Acharya
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

Review 2.  Emerging causes of viral-associated uveitis.

Authors:  Daniel B Connors; Jessica G Shantha; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2015

Review 3.  A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases.

Authors:  Manabu Mochizuki; Sunao Sugita; Koju Kamoi; Hiroshi Takase
Journal:  Jpn J Ophthalmol       Date:  2016-10-27       Impact factor: 2.447

4.  Spectrum of ocular toxicities from epidermal growth factor receptor inhibitors and their intermediate-term follow-up: a five-year review.

Authors:  Durga S Borkar; Mario E Lacouture; Surendra Basti
Journal:  Support Care Cancer       Date:  2012-11-15       Impact factor: 3.603

5.  Clinical features of human T lymphotropic virus type 1-associated uveitis in Hokkaido, Japan.

Authors:  Satoru Kase; Kenichi Namba; Nobuyoshi Kitaichi; Daiju Iwata; Shigeaki Ohno; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2013-04-23       Impact factor: 2.447

6.  Human T-cell lymphotropic virus type 1 exposures following blood-borne virus incidents in central Australia, 2002-2012.

Authors:  S Hewagama; S Krishnaswamy; L King; J Davis; R Baird
Journal:  Clin Infect Dis       Date:  2014-04-11       Impact factor: 9.079

Review 7.  Updates on HTLV-1 Uveitis.

Authors:  Koju Kamoi; Toshiki Watanabe; Kaoru Uchimaru; Akihiko Okayama; Seiko Kato; Toyotaka Kawamata; Hisako Kurozumi-Karube; Noe Horiguchi; Yuan Zong; Yoshihisa Yamano; Isao Hamaguchi; Yasuhito Nannya; Arinobu Tojo; Kyoko Ohno-Matsui
Journal:  Viruses       Date:  2022-04-12       Impact factor: 5.818

8.  HTLV-1 uveitis.

Authors:  Koju Kamoi; Manabu Mochizuki
Journal:  Front Microbiol       Date:  2012-07-24       Impact factor: 5.640

9.  Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activities.

Authors:  A Ono; E Ikeda; M Mochizuki; M Matsuoka; K Yamaguchi; T Sawada; S Yamane; S Tokudome; T Watanabe
Journal:  Jpn J Cancer Res       Date:  1998-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.